SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001020066-07-000005
Filing Date
2007-02-14
Accepted
2007-02-14 11:25:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G genz123106.txt SC 13G 4885
  Complete submission text file 0001020066-07-000005.txt   7142
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address ONE KENDALL SQ CAMBRIDGE MA 02139 6172527500
GENZYME CORP (Subject) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-37205 | Film No.: 07615707
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address SANDS CAPITAL MANAGEMENT, LLC 1100 WILSON BLVD, SUITE 3050 ARLINGTON VA 22209
Business Address SANDS CAPITAL MANAGEMENT, LLC 1100 WILSON BLVD, SUITE 3050 ARLINGTON VA 22209 703-562-4000
SANDS CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001020066 (see all company filings)

IRS No.: 202830751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G